The role of galectin-3 and its genetic variants in tumor risk and survival of patients with surgically resected early-stage non-small cell lung cancer

Autor: Akif Turna, Ilhan Yaylim, Şule Terzioğlu-Uşak, Cem Horozoglu, Seyda Demirkol
Přispěvatelé: Mühendislik ve Doğa Bilimleri Fakültesi, TERZİOĞLU, ŞULE
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Tek Nükleotid Polimorfizm Genotiplemesi
Küçük Hücreli Dışı Akciğer Kanseri
Gene Expression
Single-nucleotide polymorphism
Enzyme-Linked Immunosorbent Assay
Gastroenterology
03 medical and health sciences
0302 clinical medicine
Enzyme-linked immunosorbent assay
Enzim Bağlı İmmünosorbent Testi
single nucleotide polymorphism genotyping
Internal medicine
galectin-3
Genotype
medicine
Galectin-3
Lung cancer
non-small cell lung cancer
Univariate analysis
Predictive marker
business.industry
Hazard ratio
Area under the curve
Prognosis
medicine.disease
Non-Small Cell Lung Cancer
Gen Ekspresyonu
030104 developmental biology
Real-time polymerase chain reaction
030220 oncology & carcinogenesis
Single Nucleotide Polymorphism Genotyping
Galektin-3
gene expression
Surgery
Original Article
Terzioglu-Usak S.
Horozoglu C.
Demirkol S.
Turna A.
Yaylim I.
-The role of galectin-3 and its genetic variants in tumor risk and survival of patients with surgically resected early-stage non-small cell lung cancer-
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
cilt.29
sa.2
ss.212-222
2021

Cardiology and Cardiovascular Medicine
business
Zdroj: Turkish Journal of Thoracic and Cardiovascular Surgery
Popis: Background: The aim of this study was to investigate the possible relationship between galectin-3 gene variants, serum level, gene expression level, and the risks and survivals of resectable non-small cell lung cancer patients. Methods: The rs4644 and rs4652 variants of galectin-3 were genotyped by TaqMan single nucleotide polymorphism assay using genomic deoxyribonucleic acid isolated from the peripheral blood of 65 (54 males, 11 females; mean age: 60.1±11.9 years; range, 34 to 83 years) with Stage IA-IIIA non-small cell lung cancer who underwent primary surgical treatment and 95 healthy individuals (48 males, 47 females; mean age: 53.9±13.5 years; range, 32 to 87 years) between March 2017 and September 2018. Circulating galectin-3 levels in serum samples of the patient and control groups were assessed by enzyme-linked immunosorbent assay. Messenger ribonucleic acid expression of galectin-3 in tumor and surrounding tissues of the patient group was examined by real-time quantitative polymerase chain reaction. Both predictive and prognostic significance of the results were analyzed. Results: The presence of angiolymphatic invasion was significant in the patients with rs4652 AA genotype (p=0.04). Serum galectin-3 levels were significantly higher in the patients than the controls (p
Amaç: Bu çalışmada galektin-3 gen varyantları, serum düzeyi, gen ekspresyon düzeyi ile rezektabl küçük hücreli dışı akciğer kanseri hastalarının riskleri ve sağkalımları arasındaki olası ilişki araştırıldı. Ça­lış­ma pla­nı: Mart 2017 - Eylül 2018 tarihleri arasında galektin-3'ün rs4644 ve rs4652 varyantları, primer cerrahi tedavi yapılan küçük hücreli dışı akciğer kanserli 65 hastanın (54 erkek, 11 kadın; ort. yaş: 60.1±11.9 yıl; dağılım, 34-83 yıl) ve 95 sağlıklı bireyin (48 erkek, 47 kadın; ort. yaş: 53.9±13.5 yıl; dağılım, 32-87 yıl) periferik kanından izole edilen genomik deoksiribonükleik asitler kullanılarak TaqMan tek nükleotid polimorfizm testi ile genotiplendi. Hasta ve kontrol gruplarının serum örneklerinde dolaşımdaki galektin-3 düzeyi, enzim bağlı immünosorbent testi ile değerlendirildi. Hasta grubunda tümör ve çevre dokulardaki galektin-3’ün haberci ribonükleik asit ekspresyonu, gerçek zamanlı kantitatif polimeraz zincir reaksiyonu ile incelendi. Bu sonuçların hem prediktif, hem de prognostik önemi analiz edildi. Bulgular: Rs4652 AA genotipi olan hastalarda anjiyolenfatik invazyon varlığı anlamlı idi (p=0.04). Kontrol grubuna kıyasla, hastalarda serum galektin-3 düzeyleri anlamlı düzeyde yüksekti (p
Databáze: OpenAIRE